We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Oscar Health, Inc. (OSCR) Stock Drops Despite Market Gains: Important Facts to Note
Read MoreHide Full Article
Oscar Health, Inc. (OSCR - Free Report) closed at $15.59 in the latest trading session, marking a -8.08% move from the prior day. This move lagged the S&P 500's daily gain of 0.68%. Meanwhile, the Dow experienced a rise of 1.05%, and the technology-dominated Nasdaq saw an increase of 0.33%.
The company's shares have seen an increase of 14.21% over the last month, surpassing the Finance sector's gain of 1.58% and the S&P 500's gain of 1.8%.
Investors will be eagerly watching for the performance of Oscar Health, Inc. in its upcoming earnings disclosure. In that report, analysts expect Oscar Health, Inc. to post earnings of -$0.84 per share. This would mark a year-over-year decline of 35.48%. Simultaneously, our latest consensus estimate expects the revenue to be $3.21 billion, showing a 33.98% escalation compared to the year-ago quarter.
OSCR's full-year Zacks Consensus Estimates are calling for earnings of -$1.35 per share and revenue of $12.1 billion. These results would represent year-over-year changes of -1450% and +31.86%, respectively.
Investors might also notice recent changes to analyst estimates for Oscar Health, Inc. Such recent modifications usually signify the changing landscape of near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 4.04% higher. Oscar Health, Inc. currently has a Zacks Rank of #3 (Hold).
The Insurance - Multi line industry is part of the Finance sector. Currently, this industry holds a Zacks Industry Rank of 40, positioning it in the top 17% of all 250+ industries.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Oscar Health, Inc. (OSCR) Stock Drops Despite Market Gains: Important Facts to Note
Oscar Health, Inc. (OSCR - Free Report) closed at $15.59 in the latest trading session, marking a -8.08% move from the prior day. This move lagged the S&P 500's daily gain of 0.68%. Meanwhile, the Dow experienced a rise of 1.05%, and the technology-dominated Nasdaq saw an increase of 0.33%.
The company's shares have seen an increase of 14.21% over the last month, surpassing the Finance sector's gain of 1.58% and the S&P 500's gain of 1.8%.
Investors will be eagerly watching for the performance of Oscar Health, Inc. in its upcoming earnings disclosure. In that report, analysts expect Oscar Health, Inc. to post earnings of -$0.84 per share. This would mark a year-over-year decline of 35.48%. Simultaneously, our latest consensus estimate expects the revenue to be $3.21 billion, showing a 33.98% escalation compared to the year-ago quarter.
OSCR's full-year Zacks Consensus Estimates are calling for earnings of -$1.35 per share and revenue of $12.1 billion. These results would represent year-over-year changes of -1450% and +31.86%, respectively.
Investors might also notice recent changes to analyst estimates for Oscar Health, Inc. Such recent modifications usually signify the changing landscape of near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the business outlook.
Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 4.04% higher. Oscar Health, Inc. currently has a Zacks Rank of #3 (Hold).
The Insurance - Multi line industry is part of the Finance sector. Currently, this industry holds a Zacks Industry Rank of 40, positioning it in the top 17% of all 250+ industries.
The strength of our individual industry groups is measured by the Zacks Industry Rank, which is calculated based on the average Zacks Rank of the individual stocks within these groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Don't forget to use Zacks.com to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions.